Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub‐analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery DiseaseThe journal of clinical hypertension (Greenwich, Conn.), 2020-06, Vol.22 (6), p.1070-1079 [Peer Reviewed Journal]2020 Wiley Periodicals LLC ;2020 Wiley Periodicals LLC. ;ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/jch.13891 ;PMID: 32475050Full text available |
2 |
Material Type: Article
|
![]() |
Circular RNAs promote TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patientsOncotarget, 2017-09, Vol.8 (36), p.60280-60290Copyright: © 2017 Pan et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.19941 ;PMID: 28947970Full text available |
3 |
Material Type: Article
|
![]() |
Coronary Artery Disease WatchPharmacy times, 2021-07, Vol.87 (7), p.67COPYRIGHT 2021 Intellisphere, LLC ;ISSN: 0003-0627 ;EISSN: 2168-7234Full text available |
4 |
Material Type: Article
|
![]() |
Association between visit‐to‐visit blood pressure variability and adverse events in coronary artery disease patients after coronary interventionThe journal of clinical hypertension (Greenwich, Conn.), 2022-10, Vol.24 (10), p.1327-1338 [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals LLC. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/jch.14565 ;PMID: 36094363Full text available |
5 |
Material Type: Article
|
![]() |
Effect of cocoa (Theobroma cacao L.) on platelet function testing profiles in patients with coronary artery disease: ECLAIR pilot studyOpen heart, 2022-09, Vol.9 (2), p.e002066 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. 2022 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2022-002066 ;PMID: 36100318Full text available |
6 |
Material Type: Article
|
![]() |
Coronary artery disease risk in young women with polycystic ovary syndromeOncotarget, 2018-02, Vol.9 (9), p.8756-8764Copyright: © 2018 Ding et al. 2018 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.23985 ;PMID: 29492235Full text available |
7 |
Material Type: Article
|
![]() |
Coronary artery disease and outcomes following transcatheter aortic valve implantationOpen heart, 2024-03, Vol.11 (1), p.e002620 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002620 ;PMID: 38553013Full text available |
8 |
Material Type: Article
|
![]() |
Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? —a review of the evidences on coronary artery diseaseAnnals of cardiothoracic surgery, 2018-07, Vol.7 (4), p.506-5152018 Annals of Cardiothoracic Surgery. All rights reserved. 2018 Annals of Cardiothoracic Surgery. ;ISSN: 2225-319X ;EISSN: 2304-1021 ;DOI: 10.21037/acs.2018.05.17 ;PMID: 30094215Full text available |
9 |
Material Type: Article
|
![]() |
Dual antiplatelet therapy for secondary prevention of coronary artery diseaseOpen heart, 2017-10, Vol.4 (2), p.e000651-e000651 [Peer Reviewed Journal]Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2017 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2017-000651 ;PMID: 29081979Full text available |
10 |
Material Type: Article
|
![]() |
Low serum paraoxonase1 activity levels predict coronary artery disease severityOncotarget, 2017-03, Vol.8 (12), p.19443-19454Copyright: © 2017 Sun et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.14305 ;PMID: 28038449Full text available |
11 |
Material Type: Article
|
![]() |
Novel lipid biomarkers and ratios as risk predictors for premature coronary artery disease: A retrospective analysis of 2952 patientsThe journal of clinical hypertension (Greenwich, Conn.), 2023-12, Vol.25 (12), p.1172-1184 [Peer Reviewed Journal]2023 The Authors. published by Wiley Periodicals LLC. ;2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. ;ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/jch.14751 ;PMID: 37986641Full text available |
12 |
Material Type: Article
|
![]() |
Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbiditiesOncotarget, 2017-10, Vol.8 (46), p.80688-80699Copyright: © 2017 Wu et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.21079 ;PMID: 29113336Full text available |
13 |
Material Type: Article
|
![]() |
Extensive coronary artery disease in a long-distance athlete: a case reportJournal of athletic training, 2021-10, Vol.56 (10), p.1137-1141 [Peer Reviewed Journal]by the National Athletic Trainers' Association, Inc. ;Copyright National Athletic Trainers Association Dec 2020 ;Copyright National Athletic Trainers Association Oct 2021 ;by the National Athletic Trainers' Association, Inc 2021 2021 ;ISSN: 1062-6050 ;EISSN: 1938-162X ;DOI: 10.4085/JAT0330-20 ;PMID: 33351915Full text available |
14 |
Material Type: Article
|
![]() |
Colchicine for symptomatic coronary artery disease after percutaneous coronary interventionOpen heart, 2022-01, Vol.9 (1), p.e001887 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001887 ;PMID: 34992158Full text available |
15 |
Material Type: Article
|
![]() |
Help Patients Identify Risks for Premature Coronary Artery DiseasePharmacy times, 2023-02, Vol.89 (2)Copyright MultiMedia Healthcare Inc. 2023 ;ISSN: 0003-0627 ;EISSN: 2168-7234Full text available |
16 |
Material Type: Article
|
![]() |
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infectionOpen heart, 2020-11, Vol.7 (2), p.e001428 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2020-001428 ;PMID: 33229434Full text available |
17 |
Material Type: Article
|
![]() |
Gene-gene interaction between PPARG and CYP1A1 gene on coronary artery disease in the Chinese Han PopulationOncotarget, 2017-05, Vol.8 (21), p.34398-34404Copyright: © 2017 Zhang et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.16186 ;PMID: 28415751Full text available |
18 |
Material Type: Article
|
![]() |
External validation of novel clinical likelihood models to predict obstructive coronary artery disease and prognosisOpen heart, 2023-12, Vol.10 (2), p.e002457 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002457 ;PMID: 38056915Full text available |
19 |
Material Type: Article
|
![]() |
Health literacy interventions for secondary prevention of coronary artery disease: a scoping reviewOpen heart, 2022-01, Vol.9 (1), p.e001895 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001895 ;PMID: 35064057Full text available |
20 |
Material Type: Article
|
![]() |
Room for standardisation: the secondary prevention of coronary artery diseaseOpen heart, 2021-08, Vol.8 (2), p.e001741 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001741 ;PMID: 34413242Full text available |